# Healthpeak Properties, Inc.: Form 10-Q for the period ended Sep 30, 2014

- Company: [Healthpeak Properties, Inc.](/companies/doc.md) (CIK 765880)
- Form: 10-Q
- Filed: 2014-11-04
- Accepted by EDGAR: Nov 4, 2014, 08:34 ET
- Period: 2014-09-30
- Accession: 0001558370-14-000275
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/765880/000155837014000275/hcp-20140930x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/765880/000155837014000275/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $596.6m | us-gaap:Revenues |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $1.66bn | us-gaap:Revenues |
| Interest expense | 3 months, 2014-07-01 to 2014-09-30 | $111.3m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2014-01-01 to 2014-09-30 | $324.8m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-07-01 to 2014-09-30 | $55.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2014-01-01 to 2014-09-30 | $2.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-07-01 to 2014-09-30 | $247.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | $725.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.54 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2014-01-01 to 2014-09-30 | $1.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-07-01 to 2014-09-30 | $0.54 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2014-01-01 to 2014-09-30 | $1.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-07-01 to 2014-09-30 | 459,141,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2014-01-01 to 2014-09-30 | 458,473,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | $883.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months, 2014-01-01 to 2014-09-30 | $750.8m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2014-01-01 to 2014-09-30 | $11.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-09-30 | $83.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2014-09-30 | $20.74bn | us-gaap:Assets |
| Total liabilities | at 2014-09-30 | $9.71bn | us-gaap:Liabilities |
| Long-term debt | at 2014-09-30 | $9.12bn | us-gaap:LongTermDebt |
| Shareholders' equity | at 2014-09-30 | $10.77bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 70,865 characters.

### Cautionary Language Regarding Forward-Looking Statements

Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are “forward-looking statements.” We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. In addition, we, through our officers, from time to time, make forward-looking oral and written public statements concerning our expected future operations, strategies, securities offerings, growth and investment opportunities, dispositions, capital structure changes, budgets and other developments. Readers are cautioned that, while forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Therefore, readers should be mindful that forward-looking statements are not guarantees of future performance and that they are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, factors that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include:

(a) Changes in global, national and local economic conditions, including a prolonged period of weak economic growth;

(b) Volatility or uncertainty in the capital markets, including changes in the availability and cost of capital (impacted by changes in interest rates and the value of our common stock); which may adversely impact our ability to consummate transactions or reduce the earnings from potential transactions;

(c) Our ability to manage our indebtedness level and changes in the terms of such indebtedness;

(d) The effect on healthcare providers of recently enacted and pending Congressional legislation addressing entitlement programs and related services, including Medicare and Medicaid, which may result in future reductions in reimbursements;

(e) The ability of our operators, tenants and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;

(f) The financial weakness of some operators and tenants, including potential bankruptcies and downturns in their businesses, which results in uncertainties regarding our ability to continue to realize the full benefit of such operators’ and/or tenants’ leases;

(g) Changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations of our operators, tenants and borrowers;

(h) The potential impact of future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;

(i) Competition for tenants and borrowers, including with respect to new leases and mortgages and the renewal or rollover of existing leases;

(j) Our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to replace an existing operator or tenant upon default;

(k) Availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;

(l) The financial, legal, regulatory and reputational difficulties of significant operators of our properties;

(m) The risk that we may not be able to achieve the benefits of investments within expected time frames or at all, or within expected cost projections;

(n) The ability to obtain financing necessary to consummate acquisitions on favorable terms;

(o) The risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our joint venture partners’ financial condition and continued cooperation; and

(p) Changes in the credit ratings on United States (“U.S.”) government debt securities or default or delay in payment by the U.S. of its obligations.

Except as required by law, we undertake no, and hereby disclaim any, obligation to update any forward-looking statements, whether as a result of new information, changed circumstances or otherwise.

The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

- Executive Summary
- 2014 Transaction Overview
- Dividends
- Critical Accounting Policies
- Results of Operations
- Liquidity and Capital Resources
- Funds from Operations (“FFO”)
- Off-Balance Sheet Arrangements
- Contractual Obligations
- Inflation
- Recent Accounting Pronouncements

### Executive Summary

We are a Maryland corporation and were organized to qualify as a self-administered real estate investment trust (“REIT”) that, together with our unconsolidated joint ventures, invests primarily in real estate serving the healthcare industry in the U.S. We acquire, develop, lease, manage and dispose of healthcare real estate, and provide financing to healthcare providers. At September 30, 2014, our portfolio of investments, including properties in our Investment Management Platform, consisted of interests in 1,177 facilities. Our Investment Management Platform represents the following joint ventures: (i) HCP Ventures III, LLC, (ii) HCP Ventures IV, LLC and (iii) the HCP Life Science ventures.

Our business strategy is based on three principles: (i) opportunistic investing, (ii) portfolio diversification and (iii) conservative financing. We actively redeploy capital from investments with lower return potential or shorter investment horizons into assets representing longer term investments with attractive risk-adjusted return potential. We make investments where the expected risk-adjusted return exceeds our cost of capital and strive to capitalize on our operator, tenant and other business relationships to grow our business.

Our strategy contemplates acquiring and developing properties on terms that are favorable to us. Generally, we prefer larger, more complex private transactions that leverage our management team’s experience and our infrastructure. We follow a disciplined approach to enhancing the value of our existing portfolio, including ongoing evaluation of potential disposition of properties that no longer fit our strategy.

We primarily generate revenue by leasing healthcare properties under long term leases with fixed and/or inflation indexed escalators. Most of our rents and other earned income from leases are received under triple net leases or leases that provide for substantial recovery of operating expenses; however, some of our medical office and life science leases are structured as gross or modified gross leases. Operating expenses are generally related to medical office buildings (“MOBs”) and life science leased properties and senior housing properties managed by eligible independent contractors (“RIDEA properties”). Accordingly, for such MOBs, life science facilities and RIDEA properties, we incur certain property operating expenses, such as real estate taxes, repairs and maintenance, property management fees, utilities, employee costs for resident care and insurance. Our growth for these assets depends, in part, on our ability to (i) increase rental income and other earned income from leases by increasing rental rates and occupancy levels; (ii) maximize tenant recoveries given underlying lease structures; and (iii) control operating and other expenses. Our operations are impacted by property specific, market specific, general economic and other conditions.

### 2014 Transaction Overview

#### Brookdale Lease Amendments and Terminations and the Formation of Two RIDEA Joint Ventures (“Brookdale Transaction”)

On August 29, 2014, HCP and Brookdale Senior Living (“Brookdale”), through a Master Contribution and Transactions Agreement, closed a multiple-element transaction that has three major components:

- formed new unconsolidated joint ventures that collectively own 14 campuses of continuing care retirement communities (the “CCRC JV”). At closing, Brookdale contributed eight of its owned campuses; we contributed two campuses previously leased to Brookdale and cash used to acquire four additional campuses from third parties. HCP and Brookdale own 49% and 51%, respectively, of the CCRC JV. Brookdale continues to manage these communities;
- amended existing lease agreements on 153 HCP-owned senior housing communities, including the termination of embedded tenant purchase options relating to 30 properties and future rent reductions; and
- terminated existing lease agreements on 49 HCP-owned senior housing properties, including the termination of embedded tenant purchase options relating to 19 properties. At closing, we created a newly formed consolidated RIDEA partnership with Brookdale who is a 20% equity partner. Brookdale continues to manage the communities.

#### $630 Million (£395 Million) Debt Investment in UK Care Home Portfolio

On November 3, 2014, we committed to be the lead investor in the financing for Formation Capital and Safanad’s pending acquisition of NHP, a company that owns 273 nursing and residential care homes representing over 12,500 beds in the UK. We will provide a loan facility (the “Facility”), secured by substantially all of NHP’s assets, totaling £394.5 million (approximately $630 million), with £362.5 million funded at closing. The closing of the acquisition and funding of the Facility are expected to occur later in November 2014, subject to customary closing conditions.

#### Other Investment Transactions

During the nine months ended September 30, 2014, we completed and committed $583 million of other investments and commitments in 27 assets across our senior housing, life science and medical office segments.

During the nine months ended September 30, 2014, we funded $175 million for construction and other capital projects, primarily in our life science, medical office and senior housing segments.

#### Financing Activities

On February 1, 2014, the Company repaid $400 million of maturing senior unsecured notes, which accrued interest at a rate of 2.7%.

On February 12, 2014, we issued $350 million of 4.2% senior unsecured notes due 2024. The notes priced at 99.537% of the principal amount with an effective yield-to-maturity of 4.257%.

On March 31, 2014, we amended our unsecured revolving credit facility and increased it by $500 million to $2.0 billion. The amended facility reduces our funded interest cost by 17.5 basis points and extends the maturity date to March 31, 2018. Based on our current credit ratings, the amended facility bears interest annually at LIBOR plus 92.5 basis points and has a facility fee of 15.0 basis points. Other terms of the amended facility were substantially unchanged, including a one-year extension option at our discretion, and the ability to increase the commitments by an aggregate amount of up to $500 million, subject to customary conditions.

On August 14, 2014, we issued $800 million of 3.875% senior unsecured notes due 2024. The notes were priced at 99.63% of the principal amount with an effective yield-to-maturity of 3.92%.

### Dividends

On October 30, 2014, we announced that our Board declared a quarterly common stock cash dividend of $0.545 per share. The common stock dividend will be paid on November 25, 2014 to stockholders of record as of the close of business on November 10, 2014 and represents an annualized dividend pay rate of $2.18 per share.

### Critical Accounting Policies

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our condensed consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2013 in “Item 7. Management’s Discussion and Analysis of Financial

Condition and Results of Operations”; our critical accounting policies have not changed during 2014, except for the “Allowance for Doubtful Accounts” update included in Note 2 to the Condensed Consolidated Financial Statements.

### Results of Operations

We evaluate our business and allocate resources among our five business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the senior housing, post-acute/skilled nursing, life science and hospital segments, we primarily invest, through the acquisition and development, in single operator or tenant properties and debt issued by operators in these sectors. Under the medical office segment, we invest, through the acquisition and development, in single or multi-tenant MOBs, which generally require a greater level of property management.

We use net operating income from continuing operations (“NOI”) and adjusted NOI to assess and compare property level performance, including our same property portfolio (“SPP”), to make decisions about resource allocations, and to assess and compare property level performance. We believe these measures provide investors relevant and useful information because they reflect only income and operating expense items that are incurred at the property level and present them on an unleveraged basis. We believe that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since NOI excludes certain components from net income. Further, NOI may not be comparable to that of other REITs or real estate companies, as they may use different methodologies for calculating NOI. See Note 14 to the Condensed Consolidated Financial Statements for additional segment information and the relevant reconciliations from net income to NOI and adjusted NOI.

Operating expenses are generally related to MOB and life science leased properties and senior housing properties managed by eligible independent contractors (RIDEA properties). We generally recover all or a portion of MOB and life science expenses from the tenants (tenant recoveries). The presentation of expenses as operating or general and administrative is based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.

Our evaluation of results of operations by each business segment includes an analysis of our SPP and our total property portfolio. SPP information allows us to evaluate the performance of our leased property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year-over-year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) controls the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments, including redevelopments, are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

As part of the Brookdale Transaction, we contributed properties that were previously triple-net leased into a RIDEA structure, with Brookdale managing the communities and acquiring a 20% equity interest in the RIDEA Subsidiaries. For the properties in the RIDEA structure, we report the resident level revenues and corresponding operating expenses in our condensed consolidated financial statements rather than the triple-net rents. On August 29, 2014 (the “Closing Date”), we recorded an approximate $38 million net termination fee in rental and related revenues, which represents the termination value for the 49 leases, net of the cost to write-off the related straight-line rent assets and lease intangibles. For periods subsequent to the Closing Date, we expect increases in resident fees and services revenue and operating expenses and a decrease in rental and related revenues.

Further, we formed the unconsolidated CCRC JV, which will be managed by Brookdale. For periods subsequent to the Closing Date, we record our share of income from unconsolidated joint ventures; and as a result of deconsolidating three properties, we expect a decrease in rental and related revenues and depreciation expense.

See additional information regarding the Brookdale Transaction in Note 3 to the Condensed Consolidated Financial Statements.

### Comparison of the Three Months Ended September 30, 2014 to the Three Months Ended September 30, 2013

#### Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our five business segments. Our consolidated SPP consists of 1,021 properties representing properties acquired or placed in service and stabilized on or prior to July 1, 2013 and that remained in operations under a consistent reporting structure through September 30, 2014. Our consolidated total property portfolio represents 1,103 and 1,070 properties at September 30, 2014 and 2013, respectively, and excludes properties that were sold.

Results are as of and for the three months ended September 30, 2014 and 2013 (dollars and square feet in thousands except per capacity data):

### Senior Housing

|  | SPP Three Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Three Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues(1) | $127,282 | $126,317 | $965 | $183,834 | $149,443 | $34,391 |
| Resident fees and services | 38,419 | 36,370 | 2,049 | 62,213 | 36,370 | 25,843 |
| Total revenues | 165,701 | 162,687 | 3,014 | 246,047 | 185,813 | 60,234 |
| Operating expenses | (24,206) | (23,369) | (837) | (43,017) | (23,735) | (19,282) |
| NOI | 141,495 | 139,318 | 2,177 | 203,030 | 162,078 | 40,952 |
| Straight-line rents | (6,087) | (8,688) | 2,601 | (7,140) | (10,806) | 3,666 |
| DFL accretion | (2,230) | (2,440) | 210 | (2,230) | (2,440) | 210 |
| Amortization of above and below market lease intangibles, net | (147) | (147) | — | (147) | (148) | 1 |
| Lease termination fees | — | — | — | (38,001) | — | (38,001) |
| Adjusted NOI | $133,031 | $128,043 | $4,988 | $155,512 | $148,684 | $6,828 |
| Adjusted NOI % change |  |  | 3.9% |  |  |  |
| Property count(2) | 393 | 393 |  | 463 | 441 |  |
| Average capacity (units)(3) | 39,113 | 39,150 |  | 44,202 | 45,495 |  |
| Average annual rent per unit(4) | $13,645 | $13,125 |  | $15,889 | $15,157 |  |

(1) Represents rental and related revenues and income from direct financing leases (“DFLs”).

(2) From our past presentation of SPP for the three months ended September 30, 2013, we removed one senior housing property from SPP that was sold and 30 senior housing properties that were contributed to partnerships under a RIDEA structure as part of the Brookdale Transaction and no longer meet our criteria for SPP as of the date of contribution.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit for RIDEA properties is based on NOI.

*SPP NOI and Adjusted NOI.* SPP adjusted NOI improved as a result of annual rent increases.

*Total Portfolio NOI.* In addition to the impact of our SPP, our total portfolio NOI increased as a result of recognizing net fees of $38 million for terminating the leases on the 49 senior housing properties in the Brookdale Transaction (see Note 3 to the Condensed Consolidated Financial Statements for additional information).

### Post-Acute/Skilled Nursing

|  | SPP Three Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Three Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues | $138,885 | $135,663 | $3,222 | $139,205 | $136,017 | $3,188 |
| Operating expenses | (77) | (116) | 39 | (534) | (629) | 95 |
| NOI | 138,808 | 135,547 | 3,261 | 138,671 | 135,388 | 3,283 |
| Straight-line rents | (162) | (96) | (66) | (174) | (96) | (78) |
| DFL accretion | (16,516) | (17,338) | 822 | (16,530) | (17,382) | 852 |
| Amortization of above and below market lease intangibles, net | 11 | 11 | — | 11 | 11 | — |
| Adjusted NOI | $122,141 | $118,124 | $4,017 | $121,978 | $117,921 | $4,057 |
| Adjusted NOI % change |  |  | 3.4% |  |  |  |
| Property count(1) | 301 | 301 |  | 301 | 301 |  |
| Average capacity (beds)(2) | 38,338 | 38,219 |  | 38,400 | 38,404 |  |
| Average annual rent per bed | $12,751 | $12,374 |  | $12,761 | $12,346 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2013, we removed 11 post-acute/skilled nursing properties from SPP that were sold.

(2) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI increased primarily as a result of annual rent escalations from our HCR ManorCare, Inc. (“HCRMC”) DFL investments.

During the quarter ended September 30, 2014, we evaluated HCRMC’s financial performance, including their ability to service their obligations with us, as part of our on-going assessment of our HCRMC equity method and DFL investments. HCRMC’s fixed charge coverage, excluding certain general and professional liability (“GL/PL”) charges, which we use as our primary credit quality indicator, declined from 1.19 to 1.10 on a year-over-year trailing twelve-month basis and from 1.09 to 1.04 on a year-over-year trailing three-month basis for the periods ended September 30, 2013 and 2014, respectively; the twelve-month periods exclude $64 million and $30 million of GL/PL charges in 2013 and 2014, respectively, the quarter-over-quarter periods did not incur additional GL/PL charges. We continue to believe that all present contractual obligations, and collection and timing of all amounts owed by HCRMC under its master lease (“Master Lease”) are reasonably assured. HCRMC’s business over the near future continues to be impacted by the dynamic changes occurring in the healthcare industry, including Medicare, Medicare Advantage and Medicaid reimbursement trends, as well as changes in managed care and new evolving healthcare delivery models. As one of the premier operators in its industry, HCRMC believes that it is favorably positioned to grow as part of the ongoing changes in the healthcare environment. Based on discussions with the management of HCRMC and our evaluation of other industry data, we note the following factors that influence our evaluation of HCRMC: (i) overall net Medicare rate increases of 2.0% are effective as of October 1, 2014; (ii) additional cost cutting measures are anticipated in the fourth quarter of 2014, resulting in lower operating expenses; (iii) new facility developments and expansions will be operational in 2015; (iv) assisted living and hospice operations demonstrate continued growth and a 1.4% Medicare hospice reimbursement increase is effective October 1, 2014; and (v) year-over-year forecasted improvements in hospital admissions.

While we remain confident in HCRMC’s ongoing adjustments to their business model, there is no assurance that HCRMC will be able to reverse the decline in their financial performance. Failure of HCRMC to reverse the decline in its financial performance could cause us to conclude that we should recognize an impairment charge to reduce the carrying value of our equity method investment. A further deterioration in HCRMC’s financial performance could then lead us to conclude that the collection and timing of contractual obligations, or a portion thereof, under the HCRMC Master Lsease may not be reasonably assured. If we further determine that it is probable that we will not be able to collect all amounts due under the terms of the HCRMC Master Lease, we may incur an impairment on the applicable portion of the HCRMC DFL investment.

### Life Science

|  | SPP Three Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Three Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $62,961 | $62,128 | $833 | $66,273 | $61,891 | $4,382 |
| Tenant recoveries | 12,007 | 10,555 | 1,452 | 13,177 | 10,640 | 2,537 |
| Total revenues | 74,968 | 72,683 | 2,285 | 79,450 | 72,531 | 6,919 |
| Operating expenses | (13,948) | (12,572) | (1,376) | (16,637) | (14,091) | (2,546) |
| NOI | 61,020 | 60,111 | 909 | 62,813 | 58,440 | 4,373 |
| Straight-line rents | (1,932) | (3,100) | 1,168 | (2,119) | (1,864) | (255) |
| Amortization of above and below market lease intangibles, net | (4) | (39) | 35 | 28 | (43) | 71 |
| Lease termination fees | — | (181) | 181 | — | (181) | 181 |
| Adjusted NOI | $59,084 | $56,791 | $2,293 | $60,722 | $56,352 | $4,370 |
| Adjusted NOI % change |  |  | 4.0% |  |  |  |
| Property count(1) | 108 | 108 |  | 112 | 111 |  |
| Average occupancy | 93.6% | 91.7% |  | 93.7% | 91.8% |  |
| Average occupied square feet | 6,497 | 6,361 |  | 6,739 | 6,496 |  |
| Average annual total revenues per occupied square foot(2) | $45 | $44 |  | $46 | $43 |  |
| Average annual base rent per occupied square foot | $38 | $37 |  | $38 | $37 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2013, we removed two life science facilities from SPP that were placed into land held for development in 2014, which no longer meet our criteria for SPP as of the date placed into development.

(2) Represents rental and related revenues and tenant recoveries.

*SPP Adjusted NOI.* SPP adjusted NOI increased primarily as a result of annual rent escalations and increased occupancy.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our life science development projects placed in service during 2014 and 2013.

During the three months ended September 30, 2014, 565,000 square feet of new and renewal leases commenced at an average annual base rent of $31.59 per square foot compared to 391,000 square feet of expiring leases with an average annual base rent of $38.74 per square foot.

### Medical Office

|  | SPP Three Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Three Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $72,890 | $73,103 | $(213) | $76,876 | $73,789 | $3,087 |
| Tenant recoveries | 14,715 | 14,578 | 137 | 15,536 | 14,636 | 900 |
| Total revenues | 87,605 | 87,681 | (76) | 92,412 | 88,425 | 3,987 |
| Operating expenses | (34,767) | (34,028) | (739) | (38,459) | (35,987) | (2,472) |
| NOI | 52,838 | 53,653 | (815) | 53,953 | 52,438 | 1,515 |
| Straight-line rents | 435 | (566) | 1,001 | 334 | (299) | 633 |
| Amortization of above and below market lease intangibles, net | 235 | 259 | (24) | 174 | 282 | (108) |
| Lease termination fees | — | (24) | 24 | 20 | (24) | 44 |
| Adjusted NOI | $53,508 | $53,322 | $186 | $54,481 | $52,397 | $2,084 |
| Adjusted NOI % change |  |  | 0.3% |  |  |  |
| Property count(1) | 204 | 204 |  | 211 | 205 |  |
| Average occupancy | 91.3% | 90.9% |  | 90.7% | 90.6% |  |
| Average occupied square feet | 12,656 | 12,578 |  | 13,347 | 12,736 |  |
| Average annual total revenues per occupied square foot(2) | $28 | $28 |  | $28 | $28 |  |
| Average annual base rent per occupied square foot | $23 | $23 |  | $23 | $23 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2013, we removed three MOBs from SPP that were sold and a MOB that was placed into redevelopment in 2013, which no longer meets our criteria for SPP as of the date it was placed into redevelopment.

(2) Represents rental and related revenues and tenant recoveries.

*SPP NOI.* SPP NOI decreased primarily as a result of the write-off of straight-line rents as we determined that collectibility was not probable.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our medical office acquisitions in 2014.

During the three months ended September 30, 2014, 587,000 square feet of new and renewal leases commenced at an average annual base rent of $23.70 per square foot compared to 584,000 square feet of expiring and terminated leases with an average annual base rent of $25.88 per square foot. During the three months ended September 30, 2014, we acquired 538,000 square feet with an average annual base rent of $24.75 per square foot.

### Hospital

|  | SPP Three Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Three Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues | $20,619 | $20,151 | $468 | $20,950 | $20,185 | $765 |
| Tenant recoveries | 610 | 644 | (34) | 610 | 644 | (34) |
| Total revenues | 21,229 | 20,795 | 434 | 21,560 | 20,829 | 731 |
| Operating expenses | (950) | (975) | 25 | (952) | (975) | 23 |
| NOI | 20,279 | 19,820 | 459 | 20,608 | 19,854 | 754 |
| Straight-line rents | 476 | 372 | 104 | 472 | 371 | 101 |
| Amortization of above and below market lease intangibles, net | (342) | (342) | — | (342) | (342) | — |
| Adjusted NOI | $20,413 | $19,850 | $563 | $20,738 | $19,883 | $855 |
| Adjusted NOI % change |  |  | 2.8% |  |  |  |
| Property count(1) | 15 | 15 |  | 16 | 12 |  |
| Average capacity (beds)(2) | 2,161 | 2,146 |  | 2,221 | 2,146 |  |
| Average annual rent per bed | $39,543 | $38,822 |  | $39,063 | $38,884 |  |

(1) From our past presentation of SPP for the three months ended September 30, 2013, we removed two hospitals from SPP that were sold.

(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

#### Other Income and Expense Items

#### Interest income

Interest income decreased $25 million to $18 million for the three months ended September 30, 2014. The decrease was primarily the result of income realized from the repayment of our Barchester loan in September 2013 that was acquired earlier in 2013 (see Note 7 to the Condensed Consolidated Financial Statements for additional information).

#### Interest expense

Interest expense increased $3 million to $111 million for the three months ended September 30, 2014. The increase was primarily the result of our senior unsecured notes offerings during 2013 and 2014, partially offset by maturities of certain senior unsecured notes and mortgage debt during 2013 and 2014.

Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

| Balance: | As of September 30,(1) 2014 | 2013 |
| --- | ---: | ---: |
| Fixed rate | $9,066,872 | $8,185,353 |
| Variable rate | 78,500 | 324,902 |
| Total | $9,145,372 | $8,510,255 |
| **Percent of total debt:** |  |  |
| Fixed rate | 99.1% | 96.0% |
| Variable rate | 0.9 | 4.0 |
| Total | 100% | 100% |
| **Weighted average interest rate at end of period:** |  |  |
| Fixed rate | 5.05% | 5.21% |
| Variable rate | 1.26% | 1.57% |
| Total | 5.01% | 5.07% |

(1) At September 30, 2014, excludes $98 million of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities and demand notes that have no scheduled maturities. At September 30, 2013, excludes $78 million of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities. At both September 30, 2014 and 2013, $72 million of variable-rate mortgages and a £137 million ($222 million) term loan are presented as fixed-rate debt as the interest payments were swapped from variable to fixed.

#### Depreciation and amortization expense

Depreciation and amortization expense increased $18 million to $123 million for the three months ended September 30, 2014. The increase was primarily the result of a change in estimate of the depreciable life and residual value of certain properties and the impact of our senior housing acquisitions and our medical office and life science development projects placed in service during 2013 and 2014.

#### General and administrative expenses

General and administrative expenses decreased $20 million to $25 million for the three months ended September 30, 2014. The three months ended September 30, 2013 included $26.4 million of severance-related charges (see Note 13 to the Condensed Consolidated Financial Statements for additional information). The decrease was partially offset by increases in professional fees for transactional costs.

#### Equity income from unconsolidated joint ventures

Equity income from unconsolidated joint ventures decreased $4 million to $10 million for the three months ended September 30, 2014. The decrease was primarily the result of our share of losses recognized from the newly formed CCRC JV and an increase in our share of losses from our HCR ManorCare investment.

#### Discontinued operations

During the three months ended September 30, 2013, we sold a hospital and recognized a gain of $8 million. There were no sales of real estate during the three months ended September 30, 2014.

### Comparison of the Nine Months Ended September 30, 2014 to the Nine Months Ended September 30, 2013

#### Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our five business segments. Our consolidated SPP consists of 1,014 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2013 and that remained in operations under a consistent reporting structure through September 30, 2014. Our consolidated total property portfolio represents 1,103 and 1,070 properties at September 30, 2014 and 2013, respectively, and excludes properties that were sold.

Results are as of and for the nine months ended September 30, 2014 and 2013 (dollars and square feet in thousands except per capacity data):

### Senior Housing

|  | SPP Nine Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Nine Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues | $378,195 | $377,505 | $690 | $485,823 | $448,600 | $37,223 |
| Resident fees and services | 114,398 | 108,474 | 5,924 | 138,205 | 108,509 | 29,696 |
| Total revenues | 492,593 | 485,979 | 6,614 | 624,028 | 557,109 | 66,919 |
| Operating expenses | (72,538) | (69,127) | (3,411) | (92,388) | (70,593) | (21,795) |
| NOI | 420,055 | 416,852 | 3,203 | 531,640 | 486,516 | 45,124 |
| Straight-line rents | (22,789) | (27,446) | 4,657 | (26,953) | (34,371) | 7,418 |
| DFL accretion | (6,882) | (12,202) | 5,320 | (6,882) | (12,202) | 5,320 |
| Amortization of above and below market lease intangibles, net | (442) | (610) | 168 | (441) | (533) | 92 |
| Lease termination fees | — | — | — | (38,001) | — | (38,001) |
| Adjusted NOI | $389,942 | $376,594 | $13,348 | $459,363 | $439,410 | $19,953 |
| Adjusted NOI % change |  |  | 3.5% |  |  |  |
| Property count(1) | 388 | 388 |  | 463 | 441 |  |
| Average capacity (units)(2) | 38,682 | 38,655 |  | 45,123 | 45,495 |  |
| Average annual rent per unit(3) | $13,482 | $13,034 |  | $13,654 | $12,959 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2013, we removed one senior housing property from SPP that was sold and 30 senior housing properties that were contributed to partnerships under a RIDEA structure as part of the Brookdale Transaction and no longer meet our criteria for SPP as of the date of contribution.

(2) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(3) Average annual rent per unit for RIDEA properties is based on NOI.

*SPP Adjusted NOI.* SPP adjusted NOI improved as a result of annual rent increases.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI increased as a result of recognizing net fees of $38 million for terminating the leases on the 49 senior housing properties in the Brookdale Transaction. Our total portfolio NOI and adjusted NOI increased as a result of our senior housing acquisitions in 2014 and 2013.

### Post-Acute/Skilled Nursing

|  | SPP Nine Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Nine Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues | $414,208 | $404,053 | $10,155 | $415,533 | $405,108 | $10,425 |
| Operating expenses | (225) | (352) | 127 | (1,599) | (1,890) | 291 |
| NOI | 413,983 | 403,701 | 10,282 | 413,934 | 403,218 | 10,716 |
| Straight-line rents | (662) | (478) | (184) | (673) | (478) | (195) |
| DFL accretion | (51,012) | (53,050) | 2,038 | (51,113) | (53,184) | 2,071 |
| Amortization of above and below market lease intangibles, net | 34 | 34 | — | 34 | 34 | — |
| Adjusted NOI | $362,343 | $350,207 | $12,136 | $362,182 | $349,590 | $12,592 |
| Adjusted NOI % change |  |  | 3.5% |  |  |  |
| Property count(1) | 301 | 301 |  | 301 | 301 |  |
| Average capacity (beds)(2) | 38,338 | 38,219 |  | 38,481 | 38,404 |  |
| Average annual rent per bed | $12,608 | $12,229 |  | $12,603 | $12,202 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2013, we removed 11 post-acute/skilled nursing properties from SPP that were sold.

(2) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

*NOI and Adjusted NOI.* SPP and total portfolio NOI and adjusted NOI increased primarily as a result of annual rent escalations from our HCRMC DFL investments.

### Life Science

|  | SPP Nine Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Nine Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $185,998 | $183,110 | $2,888 | $196,384 | $188,309 | $8,075 |
| Tenant recoveries | 34,204 | 32,090 | 2,114 | 36,729 | 32,779 | 3,950 |
| Total revenues | 220,202 | 215,200 | 5,002 | 233,113 | 221,088 | 12,025 |
| Operating expenses | (39,814) | (37,165) | (2,649) | (46,247) | (41,313) | (4,934) |
| NOI | 180,388 | 178,035 | 2,353 | 186,866 | 179,775 | 7,091 |
| Straight-line rents | (6,434) | (9,689) | 3,255 | (7,480) | (8,759) | 1,279 |
| Amortization of above and below market lease intangibles, net | (8) | 160 | (168) | 74 | 135 | (61) |
| Lease termination fees | (570) | (194) | (376) | (570) | (194) | (376) |
| Adjusted NOI | $173,376 | $168,312 | $5,064 | $178,890 | $170,957 | $7,933 |
| Adjusted NOI % change |  |  | 3.0% |  |  |  |
| Property count(1) | 107 | 107 |  | 112 | 111 |  |
| Average occupancy | 92.3% | 91.4% |  | 92.4% | 91.6% |  |
| Average occupied square feet | 6,330 | 6,275 |  | 6,572 | 6,465 |  |
| Average annual total revenues per occupied square foot(1) | $45 | $44 |  | $46 | $44 |  |
| Average annual base rent per occupied square foot | $38 | $37 |  | $38 | $37 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2013, we removed two life science facilities from SPP that were placed into land held for development in 2014, which no longer meet our criteria for SPP as of the date placed into development.

(2) Represents rental and related revenues and tenant recoveries.

*SPP Adjusted NOI.* SPP adjusted NOI increased as a result of annual rent escalations and increased occupancy.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our life science development projects placed in service during 2014 and 2013.

During the nine months ended September 30, 2014, 1.1 million square feet of new and renewal leases commenced at an average annual base rent of $30.72 per square foot compared to 927,000 square feet of expiring and terminated leases with an average annual base rent of $28.92 per square foot. During the nine months ended September 30, 2014, we acquired 83,000 square feet with an average annual base rent of $33.87 per square foot.

### Medical Office

|  | SPP Nine Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Nine Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental and related revenues | $221,830 | $219,295 | $2,535 | $229,880 | $224,600 | $5,280 |
| Tenant recoveries | 41,824 | 40,308 | 1,516 | 43,335 | 40,652 | 2,683 |
| Total revenues | 263,654 | 259,603 | 4,051 | 273,215 | 265,252 | 7,963 |
| Operating expenses | (101,866) | (99,166) | (2,700) | (111,140) | (105,364) | (5,776) |
| NOI | 161,788 | 160,437 | 1,351 | 162,075 | 159,888 | 2,187 |
| Straight-line rents | (967) | (3,219) | 2,252 | (1,315) | (3,206) | 1,891 |
| Amortization of above and below market lease intangibles, net | 759 | 684 | 75 | 741 | 750 | (9) |
| Lease termination fees | (192) | (27) | (165) | (221) | (26) | (195) |
| Adjusted NOI | $161,388 | $157,875 | $3,513 | $161,280 | $157,406 | $3,874 |
| Adjusted NOI % change |  |  | 2.2% |  |  |  |
| Property count(1) | 203 | 203 |  | 211 | 205 |  |
| Average occupancy | 91.6% | 91.2% |  | 90.8% | 90.6% |  |
| Average occupied square feet | 12,636 | 12,569 |  | 13,046 | 12,748 |  |
| Average annual total revenues per occupied square foot(2) | $28 | $27 |  | $28 | $27 |  |
| Average annual base rent per occupied square foot | $23 | $23 |  | $23 | $23 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2013, we removed three MOBs from SPP that were sold and a MOB that was placed into redevelopment in 2013, which no longer meets our criteria for SPP as of the date it was placed into redevelopment.

(2) Represents rental and related revenues and tenant recoveries.

*SPP Adjusted NOI.* SPP adjusted NOI increased primarily as a result of increased occupancy and annual rent escalations.

*Total Portfolio NOI and Adjusted NOI.* In addition to the impact of our SPP, our total portfolio NOI and adjusted NOI increased primarily as a result of our medical office acquisitions in 2014 and 2013.

During the nine months ended September 30, 2014, 1.6 million square feet of new and renewal leases commenced at an average annual base rent of $22.35 per square foot compared to 1.7 million square feet of expiring and terminated leases with an average annual base rent of $24.34 per square foot. During the nine months ended September 30, 2014, we acquired 660,000 square feet with an average annual base rent of $26.95 per square foot.

### Hospital

|  | SPP Nine Months Ended September 30, 2014 | 2013 | Change | Total Portfolio Nine Months Ended September 30, 2014 | 2013 | Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Rental revenues | $61,579 | $49,112 | $12,467 | $62,569 | $49,172 | $13,397 |
| Tenant recoveries | 1,802 | 1,835 | (33) | 1,803 | 1,835 | (32) |
| Total revenues | 63,381 | 50,947 | 12,434 | 64,372 | 51,007 | 13,365 |
| Operating expenses | (2,792) | (2,828) | 36 | (2,799) | (2,830) | 31 |
| NOI | 60,589 | 48,119 | 12,470 | 61,573 | 48,177 | 13,396 |
| Straight-line rents | 1,348 | 17,971 | (16,623) | 1,328 | 17,969 | (16,641) |
| Amortization of above and below market lease intangibles, net | (1,027) | (6,482) | 5,455 | (1,027) | (6,482) | 5,455 |
| Adjusted NOI | $60,910 | $59,608 | $1,302 | $61,874 | $59,664 | $2,210 |
| Adjusted NOI % change |  |  | 2.2% |  |  |  |
| Property count(1) | 15 | 15 |  | 16 | 12 |  |
| Average capacity (beds)(2) | 2,161 | 2,146 |  | 2,221 | 2,146 |  |
| Average annual rent per bed | $39,304 | $38,798 |  | $38,825 | $38,834 |  |

(1) From our past presentation of SPP for the nine months ended September 30, 2013, we removed two hospitals from SPP that were sold.

(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

*NOI and Adjusted NOI.* SPP and total portfolio NOI increased primarily due to a net $12 million correction reducing previously recognized straight-line rents and increasing amortization of below market lease intangibles related to our Medical City Dallas hospital during 2013. SPP and total portfolio adjusted NOI increased primarily as a result of annual rent escalations.

#### Other Income and Expense Items

#### Interest income

Interest income decreased $17 million to $51 million for the nine months ended September 30, 2014. The decrease was primarily the result of interest income from the repayment of our Barchester loan in September 2013 that was acquired earlier in 2013, partially offset by the interest earned from the second tranche funding in September 2013 of our mezzanine loan facility to Tandem Health Care (see Note 7 to the Condensed Consolidated Financial Statements for additional information) made in 2013.

#### Interest expense

Interest expense decreased $1 million to $325 million for the nine months ended September 30, 2014. The decrease was primarily the result of maturities of certain senior unsecured notes and mortgage debt during 2013 and 2014, offset by our senior unsecured notes offerings during 2013 and 2014.

Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

#### Depreciation and amortization expense

Depreciation and amortization expense increased $26 million to $343 million for the nine months ended September 30, 2014. The increase was primarily the result of a change in estimate of the depreciable life and residual value of certain properties and the impact of our medical office and life science development projects placed in service and senior housing acquisitions in 2013.

#### General and administrative expenses

General and administrative expenses decreased $15 million to $75 million for the nine months ended September 30, 2014. The nine months ended September 30, 2013 included $26.4 million of severance-related charges (see Note 13 to the Condensed Consolidated Financial Statements for additional information). The decrease was partially offset by increases in professional fees for transactional costs.

#### Other income, net

Other income, net decreased $11 million to $6 million for the nine months ended September 30, 2014. The decrease was primarily the result of 2013 gains of $11 million from the sale of marketable securities.

#### Equity income from unconsolidated joint ventures

Equity income from unconsolidated joint ventures decreased $5 million to $39 million for the nine months ended September 30, 2014. The decrease was primarily the result of our share of losses recognized from the newly formed CCRC JV and an increase in our share of losses for our HCR ManorCare investment.

#### Discontinued operations

During the nine months ended September 30, 2014, we sold two post-acute/skilled nursing facilities, a hospital and a MOB, recognizing gains of $28 million. During the nine months ended September 30, 2013, we sold two properties realizing a gain of $9 million.

### Liquidity and Capital Resources

Our principal liquidity needs are to: (i) fund recurring operating expenses, (ii) meet debt service requirements including principal payments and maturities in the last three months of 2014, (iii) fund capital expenditures, including tenant improvements and leasing costs, (iv) fund acquisition and development activities, and (v) make dividend distributions. We anticipate that cash flow from continuing operations over the next 12 months will be adequate to fund our business operations, debt service payments, recurring capital expenditures and cash dividends to shareholders. Capital requirements relating to maturing indebtedness, acquisitions and development activities may require funds from borrowings and/or sales of equity and debt securities.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, as noted below, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our debt ratings. We also pay a facility fee on the entire revolving commitment that depends upon our debt ratings. As of October 30, 2014, we had a credit rating of Baa1 from Moody’s, BBB+ from Standard & Poor’s (“S&P”) and BBB+ from Fitch on our senior unsecured debt securities.

Net cash provided by operating activities was $883 million and $844 million for the nine months ended September 30, 2014 and 2013, respectively. The increase in operating cash flows is primarily the result of the following: (i) the impact from our investments in 2013 and 2014, (ii) assets placed in service during 2013 and 2014 and (iii) rent escalations and resets in 2013 and 2014. Our cash flows from operations are dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

The following are significant investing and financing activities for the nine months ended September 30, 2014:

- made investments of $939 million (development and acquisition of real estate and loans), net of proceeds from sales of real estate and loan and DFL repayments of $86 million;
- paid dividends on common stock of $751 million, which were generally funded by cash provided by our operating activities; and
- repaid $689 million of mortgages and senior unsecured notes and raised proceeds of $1.3 billion primarily from sales of senior unsecured notes and borrowings under our unsecured revolving line of credit facility.

#### Debt

#### Bank Line of Credit and Term Loan

On March 31, 2014, we amended our unsecured revolving line of credit facility (the “Facility”) with a syndicate of banks, which was scheduled to mature in March 2016, increasing the borrowing capacity by $500 million to $2.0 billion. The amended Facility matures on March 31, 2018, with a one-year committed extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends upon our debt ratings. We pay a facility fee on the entire revolving commitment that depends on our debt ratings. Based on our debt ratings at October 30, 2014, the margin on the Facility was 0.925%, and the facility fee was 0.15%. The Facility also includes a feature that will allow us to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At September 30, 2014, we had $70 million outstanding under the Facility with a weighted average effective interest rate of 1.34%.

On July 30, 2012, we entered into a credit agreement with a syndicate of banks for a £137 million ($222 million at September 30, 2014) four-year unsecured term loan (the “Term Loan”). Based on our debt ratings at September 30, 2014, the Term Loan accrues interest at a rate of GBP LIBOR plus 1.20%. Concurrent with the closing of the Term Loan, we entered into a four-year interest rate swap contract that fixes the rate of the Term Loan at 1.81%, subject to adjustments based on our debt ratings. The Term Loan contains a one-year committed extension option.

The Facility and Term Loan contain certain financial restrictions and other customary requirements. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60% and (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times. The Facility and Term Loan also require a Minimum Consolidated Tangible Net Worth of $9.5 billion at September 30, 2014. At September 30, 2014, we were in compliance with each of these restrictions and requirements of the Facility and Term Loan.

#### Senior Unsecured Notes

At September 30, 2014, we had senior unsecured notes outstanding with an aggregate principal balance of $7.7 billion. Interest rates on the notes ranged from 2.79% to 6.99% with a weighted average effective interest rate of 4.95% and a weighted average maturity of six years at September 30, 2014. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. We believe we were in compliance with these covenants at September 30, 2014.

#### Mortgage Debt

At September 30, 2014, we had $1.2 billion in aggregate principal amount of mortgage debt outstanding is secured by 88 healthcare facilities (including redevelopment properties) with a carrying value of $1.4 billion. Interest rates on the mortgage debt ranged from 0.44% to 8.69% with a weighted average effective interest rate of 6.21% and a weighted average maturity of three years at September 30, 2014.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets, and includes conditions to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

#### Debt Maturities

The following table summarizes our stated debt maturities and scheduled principal repayments at September 30, 2014 (in thousands):

| Year | Amount(1) |
| --- | ---: |
| 2014 (Three months) | $249,052 |
| 2015 | 440,164 |
| 2016 | 1,413,854 |
| 2017 | 1,300,477 |
| 2018 | 676,583 |
| Thereafter | 5,065,242 |
|  | 9,145,372 |
| (Discounts) and premiums, net | (28,580) |
|  | $9,116,792 |

(1) Excludes $98 million of other debt that represents Life Care Bonds and Demand Notes that have no scheduled maturities that are discussed below.

#### Other Debt

At September 30, 2014, we had $72 million of non-interest bearing life care bonds at two of our continuing care retirement communities and non-interest bearing occupancy fee deposits at two of our senior housing facilities, all of which were payable to certain residents of the facilities (collectively, “Life Care Bonds”). The Life Care Bonds are generally refundable to the residents upon the termination of the contract or upon the successful resale of the unit.

In conjunction with the Brookdale Transaction, on August 29, 2014, we borrowed $26 million from the CCRC JV in the form of on-demand notes (“Demand Notes”). The Demand Notes mature on June 30, 2015 and bears interest at a rate of 4.5%.

#### Derivative Instruments

We use derivative instruments to mitigate the effects of interest rate and foreign currency fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. We do not use derivative instruments for speculative or trading purposes.

The following table summarizes our outstanding interest-rate and foreign currency swap contracts as of September 30, 2014 (dollars and GBP in thousands):

| Date Entered | Maturity Date | Hedge Designation | Fixed Rate/Buy Amount | Floating/Exchange Rate Index | Notional/ Sell Amount | Fair Value |
| --- | --- | --- | ---: | --- | ---: | ---: |
| July 2005(1) | July 2020 | Cash Flow | 3.82% | BMA Swap Index | $45,600 | $(5,635) |
| November 2008 | October 2016 | Cash Flow | 5.95% | 1 Month LIBOR+1.50% | $26,000 | $(1,945) |
| July 2012 | June 2016 | Cash Flow | 1.81% | 1 Month GBP LIBOR+1.20% | £137,000 | $1,447 |
| July 2012 | June 2016 | Cash Flow | $45,500 | Buy USD/Sell GBP | £29,000 | $(1,337) |
| July 2014 | December 2015 | Cash Flow | $9,300 | Buy USD/Sell GBP | £5,500 | $484 |

(1) Represents three interest-rate swap contracts, which hedge fluctuations in interest payments on variable-rate secured debt due to overall changes in hedged cash flows.

For a more detailed description of our derivative instruments, see Note 20 to the Condensed Consolidated Financial Statements and “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

#### Equity

At September 30, 2014, we had 459 million shares of common stock outstanding. At September 30, 2014, equity totaled $11.0 billion, and our equity securities had a market value of $18.5 billion.

At September 30, 2014, non-managing members held an aggregate of 4 million units in five limited liability companies (“DownREITs”) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).

#### Shelf Registration

We have a prospectus that we filed with the U.S. Securities and Exchange Commission (the “SEC”) as part of a registration statement on Form S-3ASR, using a shelf registration process which expires in July 2015. Under the “shelf” process, we may sell any combination of the securities described in the prospectus in one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.

### Funds From Operations (“FFO”)

We believe FFO applicable to common shares, diluted FFO applicable to common shares, and basic and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.

FFO is defined as net income applicable to common shares (computed in accordance with GAAP), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income. We compute FFO in accordance with the current National Association of Real Estate Investment Trusts’ (“NAREIT”) definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from ours. FFO as adjusted represents FFO before the impact of impairments (recoveries) of non-depreciable assets, transaction-related items (defined below), severance-related items and preferred stock redemption charges. Management believes that FFO as adjusted is useful to investors, because it allows investors to compare our results to prior reporting periods without the effect of items that by their nature would not be comparable. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income or NAREIT FFO.

Details of certain items that affect comparability are discussed under “Results of Operations” above. The following is a reconciliation of net income applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO (in thousands, except per share data):

|  | Three Months Ended September 30, 2014 | 2013 | Nine Months Ended September 30, 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Net income applicable to common shares | $247,208 | $233,282 | $723,651 | $676,412 |
| Depreciation and amortization of real estate, in-place lease and other intangibles: |  |  |  |  |
| Continuing operations | 122,975 | 104,783 | 343,496 | 317,172 |
| Discontinued operations | — | 1,509 | — | 4,604 |
| Other depreciation and amortization | 4,769 | 3,631 | 12,571 | 10,589 |
| Gain on sales of real estate | — | (8,298) | (28,010) | (9,185) |
| Equity income from unconsolidated joint ventures | (10,168) | (13,892) | (39,388) | (44,278) |
| FFO from unconsolidated joint ventures | 14,571 | 16,642 | 48,683 | 52,539 |
| Noncontrolling interests’ and participating securities’ share in earnings | 3,851 | 3,576 | 13,310 | 10,955 |
| Noncontrolling interests’ and participating securities’ share in FFO | (5,902) | (5,162) | (17,425) | (15,569) |
| FFO applicable to common shares | 377,304 | 336,071 | 1,056,888 | 1,003,239 |
| Distributions on dilutive convertible units | 3,486 | 3,302 | 10,327 | 9,966 |
| Diluted FFO applicable to common shares | $380,790 | $339,373 | $1,067,215 | $1,013,205 |
| Diluted FFO per common share | $0.82 | $0.73 | $2.30 | $2.20 |
| Weighted average shares used to calculate diluted FFO per common share | 465,247 | 462,082 | 464,512 | 461,403 |

55

|  | Three Months Ended September 30, 2014 | 2013 | Nine Months Ended September 30, 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Net income applicable to common shares | $0.54 | $0.51 | $1.58 | $1.49 |
| Depreciation and amortization of real estate, in-place lease and other intangibles | 0.26 | 0.23 | 0.75 | 0.70 |
| Other depreciation and amortization | 0.01 | 0.01 | 0.02 | 0.02 |
| Gain on sales of real estate | — | (0.02) | (0.06) | (0.02) |
| Joint venture and participating securities FFO adjustments | 0.01 | — | 0.01 | 0.01 |
| Diluted FFO applicable to common shares | $0.82 | $0.73 | $2.30 | $2.20 |
| Impact of adjustments to FFO: |  |  |  |  |
| Transaction-related items(1) | $(31,778) | $— | $(24,939) | $— |
| Severance-related charges(2) | — | 26,374 | — | 26,374 |
|  | $(31,778) | $26,374 | $(24,939) | $26,374 |
| FFO as adjusted applicable to common shares | $345,526 | $362,445 | $1,031,949 | $1,029,613 |
| Distributions on dilutive convertible units and other | 3,554 | 3,247 | 10,383 | 9,907 |
| Diluted FFO as adjusted applicable to common shares | $349,080 | $365,692 | $1,042,332 | $1,039,520 |
| Diluted FFO as adjusted per common share | $0.75 | $0.79 | $2.24 | $2.25 |
| Weighted average shares used to calculate diluted FFO as adjusted per common share | 465,247 | 462,082 | 464,512 | 461,403 |

(1) Transaction-related items include significant direct costs (e.g., pursuit, due diligence and closing) and gains/charges incurred as a result of mergers and acquisitions and lease amendment or restructure activities. The nine months ended September 30, 2014, include the impact of $25 million resulting primarily from the Brookdale Transaction, consisting of:

(i) $108 million of net gains related to the terminated leases of the HCP owned 49-property portfolio; partially offset by a

(ii) $70 million charge to write-off the existing straight-line rents and intangible other assets, net related to the terminated leases of the 49-property portfolio; and

(iii) $13 million in charges for direct costs.

(2) Severance-related charges were attributable to the termination of the Company’s former Chairman, Chief Executive Officer and President on October 2, 2013.

### Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures as described under Note 8 to the Condensed Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable. In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities, as described under Note 12 to the Condensed Consolidated Financial Statements. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described below under “Contractual Obligations.”

### Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at September 30, 2014 (in thousands):

|  | Total(1) | Less than One Year | 2015-2016 | 2017-2018 | More than Five Years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Line of credit | $70,000 | $— | $— | $70,000 | $— |
| Term loan(2) | 222,118 | — | 222,118 | — | — |
| Senior unsecured notes | 7,650,000 | — | 1,300,000 | 1,350,000 | 5,000,000 |
| Mortgage debt | 1,203,254 | 249,052 | 331,900 | 557,060 | 65,242 |
| Construction loan commitments(3) | 13,157 | 676 | 12,481 | — | — |
| Development commitments(4) | 73,213 | 22,312 | 50,901 | — | — |
| Ground and other operating leases | 245,675 | 1,588 | 12,249 | 9,777 | 222,061 |
| Interest(5) | 2,567,211 | 51,732 | 801,435 | 545,290 | 1,168,754 |
| Total | $12,044,628 | $325,360 | $2,731,084 | $2,532,127 | $6,456,057 |

(1) Excludes $98 million of other debt that represents Life Care Bonds and Demand Notes that have no scheduled maturities.

(2) Represents £137 million translated into U.S. dollars.

(3) Represents commitments to finance development projects and related working capital.

(4) Represents construction and other commitments for developments in progress.

(5) Interest on variable-rate debt is calculated using rates in effect at September 30, 2014.

### Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, post-acute/skilled nursing and hospital leases require the operator or tenant to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the operator or tenant expense reimbursements and contractual rent increases described above.

### Recent Accounting Pronouncements

See Note 2 to the Condensed Consolidated Financial Statements for the impact of new accounting standards. There are no accounting pronouncements that have been issued, but not yet adopted by us, that we believe will materially impact our condensed consolidated financial statements.

## Market risk

As filed, 3,385 characters.

We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the condensed consolidated balance sheets at fair value. See Note 20 to the Condensed Consolidated Financial Statements for additional information.

To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $4 million. See Note 20 to the Condensed Consolidated Financial Statements for additional analysis details.

*Interest Rate Risk.* At September 30, 2014, we are exposed to market risks related to fluctuations in interest rates primarily on variable rate investments, which has been predominately hedged through interest rate swap contracts.

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets unless such instruments mature or are otherwise terminated. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate investments and variable-rate debt, and assuming no other changes in the outstanding balance as of September 30, 2014, net interest income would improve by approximately $40,000, or less than $0.01 per common share on a diluted basis.

*Foreign Currency Risk.* At September 30, 2014, our exposure to foreign currencies primarily relates to UK investments in leased real estate, senior unsecured notes and the related GBP denominated cash flows from such investments. Our foreign currency exposure is partially mitigated through the use of GBP denominated borrowings and foreign currency swap contracts.

*Market Risk.* We have investments in marketable debt securities classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At September 30, 2014, the fair value and carrying value of marketable debt securities were $272 million and $240 million, respectively.

## Controls and procedures

As filed, 2,049 characters.

*Evaluation of Disclosure Controls and Procedures.* We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934), management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2014. Based upon that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

*Changes in Internal Control Over Financial Reporting.* There were no changes in our internal control over financial reporting during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 161 characters.

There are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2013.

Filed Nov 4, 2014.
Source: SEC EDGAR, the filing index for accession 0001558370-14-000275. Last ingested by Listed: Nov 14, 2026, 21:09 ET. No prices; not investment advice.
